Volume 35, Issue 12 pp. 1498-1504

Fluoroscopic and Electrical Assessment of a Series of Defibrillation Leads: Prevalence of Externalized Conductors

VIVEK N. KODOTH M.D.

VIVEK N. KODOTH M.D.

Cardiology Department, Royal Victoria Hospital, Belfast, Northern Ireland, United Kingdom

Search for more papers by this author
EMILY C. HODKINSON M.B.Ch.B.

EMILY C. HODKINSON M.B.Ch.B.

Cardiology Department, Royal Victoria Hospital, Belfast, Northern Ireland, United Kingdom

Search for more papers by this author
REBECCA L. NOAD M.B.Ch.B.

REBECCA L. NOAD M.B.Ch.B.

Cardiology Department, Royal Victoria Hospital, Belfast, Northern Ireland, United Kingdom

Search for more papers by this author
KYLE P. ASHFIELD B.Sc., C.D.D.S.

KYLE P. ASHFIELD B.Sc., C.D.D.S.

Cardiology Department, Royal Victoria Hospital, Belfast, Northern Ireland, United Kingdom

Search for more papers by this author
NICHOLAS A. CROMIE M.D.

NICHOLAS A. CROMIE M.D.

Cardiology Department, Royal Victoria Hospital, Belfast, Northern Ireland, United Kingdom

Queen's University, Belfast, Northern Ireland, United Kingdom

Search for more papers by this author
DAVID J. McENEANEY M.D.

DAVID J. McENEANEY M.D.

Cardiology Department, Craigavon Area Hospital, Portadown, Northern Ireland, United Kingdom

Queen's University, Belfast, Northern Ireland, United Kingdom

Search for more papers by this author
CAROL M. WILSON M.D.

CAROL M. WILSON M.D.

Cardiology Department, Royal Victoria Hospital, Belfast, Northern Ireland, United Kingdom

Search for more papers by this author
MICHAEL J. D. ROBERTS M.D.

MICHAEL J. D. ROBERTS M.D.

Cardiology Department, Royal Victoria Hospital, Belfast, Northern Ireland, United Kingdom

Queen's University, Belfast, Northern Ireland, United Kingdom

Search for more papers by this author
First published: 04 October 2012
Citations: 26
Address for reprints: Vivek N. Kodoth, M.D., Cardiology Department, Royal Victoria Hospital, Belfast, Northern Ireland, BT12 6BA, UK. Fax: 442890635738; e-mail: [email protected]

Kodoth, Ashfield Cromie: No disclosures to declare.

E. Hodkinson: Sponsorship from SJM, Pfizer, Attendance at Medtronic and Boston Scientific training courses.

R.L. Noad: Honorarium from Medtronic, Servier, Astra Zeneca Pharmaceuticals, Abbott Laboratories, Boehringer Ingelheim.

D.J. McEneaney: Honorarium from St. Jude Medical/Medtronic/Biotronik.

C.M. Wilson: Honorarium from Medtronic, Boston Scientific Corp., Pfizer, Inc., St. Jude Medical, Boehringer Ingelheim, Servier.

M.J. Roberts: Honorarium from St. Jude Medical, Medtronic, Sanofi Aventis, Boston Scientific Corp., Personalis.

Abstract

Introduction : Insulation defects with externalized conductors have been reported in the St. Jude Riata® family of defibrillation leads (St. Jude Medical, Sylmar, CA, USA). The objective of the Northern Ireland Riata® lead screening program was to identify insulation defects and externalized conductors by systematic fluoroscopic and electrical assessment in a prospectively defined cohort of patients. We sought to estimate the prevalence, identify risk factors, and determine the natural history of this abnormality.

Methods : All patients with a Riata® lead under follow-up at the Royal Victoria Hospital were invited for fluoroscopic imaging and implantable cardioverter-defibrillator lead parameter checks. Fluoroscopic images were read independently by two cardiologists and the presence of externalized conductors was classified as positive, negative, or borderline.

Results: One hundred and sixty-five of 212 patients with a Riata lead were evaluated by fluoroscopy and lead parameter measurements. The mean duration after implantation was 3.98+/−1.43 years. After screening 25 (15%) patients were classified as positive, 137 (83%) negative, and three (1.8%) borderline. Time since implantation (P = 0.001), presence of a single coil lead (P = 0.042), and patient age (P = 0.034) were significantly associated with externalized conductors. The observed rate of externalized conductors was 26.9% for 8-French and 4.7% for 7-French leads. No leads that were identified prospectively with externalized conductors had electrical abnormalities. Seven of 25 (28%) patients had a defective lead extracted by the end of this screening period.

Conclusion: A significant proportion (15%) of patients with a Riata lead had an insulation breach 4 years after implantation. High-resolution fluoroscopic imaging in at least two orthogonal views is required to identify this abnormality. (PACE 2012;35:1498–1504)

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.